In high-risk patients with hypertension, what effect do chlorthalidone, amlodipine, and lisinopril have on hospitalized or fatal heart failure (HF)? Does the effect differ across time and prespecified subgroups?
M a i n r e s u l t s
The hazard ratios (relative risks [RRs]) were not constant over time, so results are presented according to time periods (Table) . The effects were consistent across prespecified subgroups (men vs women, < 65 y vs ≥ 65 y of age, black vs nonblack patients, and patients with diabetes vs those without) with no significant interactions among subgroups.
C o n c l u s i o n s
In high-risk patients with hypertension, the risk for hospitalized or fatal heart failure was higher with lisinopril or amlodipine than with chlorthalidone during year 1. The risk remained higher with amlodipine than with chlorthalidone after year 1 (although the difference in risk was smaller), and the difference with lisinopril was no longer significant. The effects were consistent across prespecified subgroups. 
C o m m e n t a r y
The main ALLHAT trial focused on combined fatal coronary heart disease (CHD) or nonfatal myocardial infarction as the primary endpoint. The report by Davis and colleagues explores an important secondary outcome-the differential effect of treatment type on HF incidence. HF remains a common and serious cardiovascular complication despite obvious advances in antihypertensive treatment and control. Of significance, the cohort started with 36% with diabetes, 25% with previously documented CHD, and 53% men. The observed association of the dihydropyridine calcium-channel blocker (CCB) amlodipine with increased rates of HF is hardly surprising, given its tendency to cause fluid retention. The weaker (not statistically significant) association with lisinopril use seems counterintuitive, since angiotensin-converting enzyme (ACE) inhibitors usually reduce afterload and have decreased HF rates in other studies. Potential explanations include chance, less effective blood pressure reduction, delayed effect compared with diuretics, and confounding cotherapies after year
